Feasibility Study of Biobehavioral Stress Reduction Intervention in Patients With Triple Negative Breast Cancer
Examining the Feasibility of Implementing a Biobehavioral Stress Reduction Program in Triple Negative Breast Cancer Patients
Ohio State University Comprehensive Cancer Center
40 participants
Dec 14, 2022
INTERVENTIONAL
Conditions
Summary
This clinical trial aims to see if patients with triple negative breast cancer can complete a biobehavioral stress reduction program that also addresses health related social needs (e.g., utilities, transportation, etc.). The stress reduction program is over ten weeks and includes stress reduction (e.g., progressive muscle relaxation), coping, problem solving, communication, and social support. Health related social needs will be evaluated at the beginning of the study, and referrals will be made to social work to help address those needs. The study will examine stress as reported by the patients and also use biological markers.
Eligibility
Inclusion Criteria3
- Age \>=18 years
- Untreated newly diagnosed triple negative breast cancer
- Stages I-III
Exclusion Criteria6
- Prisoners
- Male
- Identifying as American Indian, Alaska Native, Asian, Native Hawaiian or Other Pacific Islander
- Individuals not able to speak and understand English
- Known personal history of ductal carcinoma in situ (DCIS) or invasive breast cancer
- Stage IV breast cancer
Interventions
Undergo blood sample collection
Undergo medical cart review
Receive biobehavioral stress reduction intervention
Ancillary studies
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05677802